home / stock / brax:cc / brax:cc news

BRAX:CC News and Press, Braxia Scientific Corp. From 02/01/24

Stock Information
Company Name: Braxia Scientific Corp.
Stock Symbol: BRAX:CC
Market: CNQC
Menu
BRAX:CC BRAX:CC Quote BRAX:CC Short BRAX:CC News BRAX:CC Articles BRAX:CC Message Board
Get BRAX:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
BRAX:CC - Canadian Companies Moving the Markets, Morning edition
Thu, Feb 01, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada None (CANN) fell 33.3% to $0.01 on volume of 8,166,252 shares None (FIT) fell 33.3% to $0.005 on volume of 3,869,145 shares iShares ESG Aware MSCI Emerging Markets Index ETF (XSEM) rose 0.0% to $18.02 on volume of 3,536,629 shares Blue Horizon...
BRAX:CC - Braxia Scientific Reports Mandatory Conversion of Debentures

Toronto, Ontario--(Newsfile Corp. - January 15, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), a medical research company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders,...

BRAX:CC - Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - November 30, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research company with clinics providing innovative ketamine and psilocybin treatments for depression and related ...

BRAX:CC - Braxia Scientific Reports Q1 Fiscal 2024 Financial Results

Toronto, Ontario--(Newsfile Corp. - August 30, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and rel...
BRAX:CC - Braxia Scientific Reports Fiscal 2023 Financial Results

Braxia Health ketamine treatments up 26% YoY in 2023 and revenue up 27% YoY Company completes dosing of final participant in Phase 2, multi-dose Psilocybin trial, results expected to be published prior to end of 2023 Company reviewing financing options, strategic partnerships and further co...

BRAX:CC - RETRANSMISSION: Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic

Company Taking Strategic Actions to Prioritize Clinic Expansion, Enhance Operational Effectiveness and Right Size Cost Structure This release adds information to the press release disseminated on June 9, 2023 Toronto, Ontario--(Newsfile Corp. - June 12, 2023) - Braxia Scientific Corp. (CSE: B...

BRAX:CC - Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic

Company Taking Strategic Actions to Prioritize Clinic Expansion, Enhance Operational Effectiveness and Right Size Cost Structure Toronto, Ontario--(Newsfile Corp. - June 9, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia", or the "Company"), a medical research ...
BRAX:CC - Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine and Psychedelics Clinical IP

Toronto, Ontario--(Newsfile Corp. - March 16, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC PINK: BRAXF) (FWB: 4960) ("Braxia", or the "Company"), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorde...

BRAX:CC - Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals

Braxia Health ketamine treatments up 29% YoY in Q3 2023 and revenue up 50.5% YoY Toronto, Ontario--(Newsfile Corp. - March 1, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), a medical research and telemedicine company with cli...

BRAX:CC - Braxia Scientific Announces Closing of First Tranche of LIFE Offering and Concurrent Private Placement

Toronto, Ontario--(Newsfile Corp. - February 27, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia", or the "Company"), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders, is pleased to annou...
Previous 10 Next 10